Christ the Redeemer in Yellow and Red for the Hepatitis Awareness Week

Thursday, May 19, 2011 General News J E 4

SAO PAULO, May 19, 2011 /PRNewswire/ -- The famous statue of Christ, in Rio de Janeiro is changing colors on May 19th and 20th. The statue will leave its traditional white illumination, and take the hep colors to call attention to what is being known as the "epidemy of the century."

(Photo: )

With as many as half a billion people infected in the world, the need to test the population for the virus detection is urgent, says Humberto Silva, president of the Brazilian Association for Hepatitis Patients. – "Only 10% of those infected are aware of their disease." The whole rest of them don't have any idea they are carrying an assassin inside their bodies.

The disease is known as a silent killer, because it can stay for many years, destroying one's liver without giving any sign or symptom. When the first symptom emerges, it is usually too late and the patient is near death.

Hepatitis is the main cause for liver transplantation in the world, accounting for 80% of the procedures. It can cause severe liver damage such as cirrhosis and liver tumor.

But if the virus is found in time, there is treatment and cure.

Detection is the best prevention.

The statue of Christ will also pay homage to those who are fighting a hard battle against the disease and for the hundreds of thousands who have died because of the hepatitis virus.

This year the celebrations for the World awareness for hepatitis will be split between this week of May and July 28th (a new date suggested by the World Health Organization)

More information can be found on the following sites:

SOURCE Associacao Brasileira dos portadores de Hepatite



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
/R E P E A T -- The Tourette Syndrome Foundation o...
Venture-Backed Biotech Generates Quicker Exits but...